In the 1,301 patients enrolled, hypoxemia occurred in 57 of the 624 patients, or 9.1 percent, in the noninvasive ventilation group and 118 of the 637 patients, or 18.5 percent, in the oxygen mask group. Further, it appeared that by preventing hypoxemia during tracheal intubation, preoxygenation with noninvasive ventilation also prevented cardiac arrest, the most feared complication of tracheal intubation, which occurred in one patient in the noninvasive ventilation group and seven patients in the oxygen mask group.
These findings were important because they could change the standard of care for intubations in emergency departments and intensive care units, according to Dr. Stephen Halliday, assistant professor of medicine, who along with Dr. Micah Long, associate professor of anesthesiology, both at the UW School of Medicine and Public Health, led the trial locally at the school and UW Health.
“The study illustrates how involvement in pragmatic clinical trials at academic health systems can yield data that ultimately improve outcomes for patients,” said Halliday, who is also a pulmonologist at UW Health.
Prior to this trial, international guidelines stated that preoxygenation with either noninvasive ventilation or an oxygen mask is acceptable, but results of this trial could lead to changes to those clinical guidelines, according to the study’s authors.
“Applying these results to clinical care by routinely using noninvasive ventilation for preoxygenation before tracheal intubation has the potential to prevent tens of thousands of patients each year from experiencing hypoxemia and cardiac arrest,” said Dr. Kevin Gibbs, first author on the study and a critical care medicine physician at Wake Forest School of Medicine.